JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M111419200 on December 20, 2001

J. Biol. Chem., Vol. 277, Issue 9, 7136-7143, March 1, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/9/7136    most recent
M111419200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pind, S.
Right arrow Articles by Natowicz, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pind, S.
Right arrow Articles by Natowicz, M. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

V490M, a Common Mutation in 3-Phosphoglycerate Dehydrogenase Deficiency, Causes Enzyme Deficiency by Decreasing the Yield of Mature Enzyme*

Steven PindDagger §, Elzbieta SlominskiDagger , Jill MautheDagger , Kayla Pearlman, Kathryn J. Swoboda||, John A. Wilkins**, Patricia Sauder**, and Marvin R. NatowiczDagger Dagger §§

From the Dagger  Department of Biochemistry and Medical Genetics and ** Departments of Internal Medicine and Immunology, University of Manitoba, Winnipeg, Manitoba R3E 0W3, Canada, the  Division of Medical Genetics, Shriver Center for Mental Retardation, Waltham, Massachusetts 02452, the || Departments of Neurology and Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah 84132, and Dagger Dagger  Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114

A deficiency of 3-phosphoglycerate dehydrogenase (PHGDH) is a disorder of serine biosynthesis identified in children with congenital microcephaly, seizures, and severe psychomotor retardation. We report here the identification of the 1468Gright-arrowA (V490M) mutation of this gene in two siblings of an Ashkenazi Jewish family, providing further evidence that the V490M mutation is a common, panethnic cause of this deficiency. Using a novel, DNA-based diagnostic test, the mutation was not detected in 400 non-Jewish controls; one heterozygote was found among 400 persons of Ashkenazi Jewish ethnicity. Extensive biochemical studies were undertaken to characterize the effect of this mutation on enzyme activity, turnover, and stability. The V490M PHGDH yielded less than 35% of the activity observed for the wild-type enzyme when overexpressed by transient transfection or when comparing the endogenous activity in fibroblast cells from the patients with controls. Immunoblotting studies showed a comparable reduction in the level of immunoreactive PHGDH in cells expressing the mutant enzyme. Pulse-chase experiments with metabolically labeled PHGDH indicated that this resulted from an increased rate of degradation of the mutant enzyme following its synthesis. Thermolability analyses of mutant and wild-type enzyme activity revealed no significant differences. While others have proposed that the V490M mutation decreases the Vmax of the enzyme, we conclude that this mutation impairs the folding and/or assembly of PHGDH but has minimal effects on the activity or stability of that portion of the V490M mutant that reaches a mature conformation.


* This work was supported by operating grants from the Canadian Institutes of Health Research (CIHR; Grant MT-14065) and the Manitoba Health Research Council (MHRC), studentships from the Children's Hospital Foundation of Manitoba and the MHRC (to J. M.), and a New Investigator Award from the CIHR (to S. P.). The PHGDH antibody was generated in and subsidized by the Canadian Genetic Diseases Network Immunoprobes Facility (managed by J. A. W.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed. Tel.: 204-789-3603; Fax: 204-789-3900; E-mail: spind@cc.umanitoba.ca.

§§ Present address: Dept. of Neurology, Cleveland Clinic Foundation, Cleveland, OH 44195.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J EndocrinolHome page
M. L Nagpal, Y. Chen, and T. Lin
Effects of overexpression of CXCL10 (cytokine-responsive gene-2) on MA-10 mouse Leydig tumor cell steroidogenesis and proliferation
J. Endocrinol., December 1, 2004; 183(3): 585 - 594.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.